109 related articles for article (PubMed ID: 26061105)
1. Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agents.
Couto M; de Ovalle S; Cabrera M; Cerecetto H; González M
Future Med Chem; 2015; 7(7):857-71. PubMed ID: 26061105
[TBL] [Abstract][Full Text] [Related]
2. New hits as phase II enzymes inducers from a focused library with heteroatom-heteroatom and Michael-acceptor motives.
Cabrera M; de Ovalle S; Bollati-Fogolín M; Nascimento F; Corbelini P; Janarelli F; Kawano D; Eifler-Lima VL; González M; Cerecetto H
Future Sci OA; 2015 Nov; 1(3):FSO20. PubMed ID: 28031894
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver.
Prochaska HJ; Talalay P
Cancer Res; 1988 Sep; 48(17):4776-82. PubMed ID: 3409219
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro.
Brooks JD; Goldberg MF; Nelson LA; Wu D; Nelson WG
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):868-75. PubMed ID: 12223431
[TBL] [Abstract][Full Text] [Related]
5. Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.
Dinkova-Kostova AT; Abeygunawardana C; Talalay P
J Med Chem; 1998 Dec; 41(26):5287-96. PubMed ID: 9857096
[TBL] [Abstract][Full Text] [Related]
6. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
Cabrera M; Mastandrea I; Otero G; Cerecetto H; González M
Bioorg Med Chem; 2016 Apr; 24(8):1665-74. PubMed ID: 26970663
[TBL] [Abstract][Full Text] [Related]
7. The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations.
Spencer SR; Xue LA; Klenz EM; Talalay P
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):711-7. PubMed ID: 1900000
[TBL] [Abstract][Full Text] [Related]
8. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes.
Gerhäuser C; You M; Liu J; Moriarty RM; Hawthorne M; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 1997 Jan; 57(2):272-8. PubMed ID: 9000567
[TBL] [Abstract][Full Text] [Related]
9. Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
Cabrera M; Lavaggi ML; Croce F; Celano L; Thomson L; Fernández M; Pintos C; Raymondo S; Bollati M; Monge A; López de Ceráin A; Piro OE; Cerecetto H; González M
Bioorg Med Chem; 2010 Jul; 18(14):5391-9. PubMed ID: 20639112
[TBL] [Abstract][Full Text] [Related]
10. Cancer chemopreventive activity mediated by 4'-bromoflavone, a potent inducer of phase II detoxification enzymes.
Song LL; Kosmeder JW; Lee SK; Gerhäuser C; Lantvit D; Moon RC; Moriarty RM; Pezzuto JM
Cancer Res; 1999 Feb; 59(3):578-85. PubMed ID: 9973203
[TBL] [Abstract][Full Text] [Related]
11. Induction of NAD(P)H quinone oxidoreductase by vegetables widely consumed in Catalonia, Spain.
Laso N; Mas S; Lafuente MJ; Llobet JM; Molina R; Ballesta A; Kensler TW; Lafuente A
Nutr Cancer; 2005; 52(1):49-58. PubMed ID: 16091004
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effects of Furan-2-yl-3-pyridin-2-yl-propenone against 7,12-dimethylbenz[a]anthracene-inducible genotoxicity.
Hwang YP; Han EH; Choi JH; Kim HG; Lee KJ; Jeong TC; Lee ES; Jeong HG
Toxicol Appl Pharmacol; 2008 May; 228(3):343-50. PubMed ID: 18255114
[TBL] [Abstract][Full Text] [Related]
13. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
[TBL] [Abstract][Full Text] [Related]
14. Quinone reductase induction as a biomarker for cancer chemoprevention.
Cuendet M; Oteham CP; Moon RC; Pezzuto JM
J Nat Prod; 2006 Mar; 69(3):460-3. PubMed ID: 16562858
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes.
Zhang Y; Talalay P
Cancer Res; 1998 Oct; 58(20):4632-9. PubMed ID: 9788615
[TBL] [Abstract][Full Text] [Related]
17. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
[TBL] [Abstract][Full Text] [Related]
18. Differential response of four human livers to modulation of phase II enzyme systems by the chemopreventive phytochemical phenethyl isothiocyanate.
Konsue N; Ioannides C
Mol Nutr Food Res; 2010 Oct; 54(10):1477-85. PubMed ID: 20440691
[TBL] [Abstract][Full Text] [Related]
19. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
Begleiter A; Leith MK; Curphey TJ; Doherty GP
Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction events elicited by cancer prevention compounds.
Kong AN; Yu R; Hebbar V; Chen C; Owuor E; Hu R; Ee R; Mandlekar S
Mutat Res; 2001 Sep; 480-481():231-41. PubMed ID: 11506817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
